I 

118TH CONGRESS 

2D SESSION H. R. 7183 

To prohibit Federal funds from being used to provide certain gender transition 

procedures to minors. 

IN THE HOUSE OF REPRESENTATIVES 

FEBRUARY 1, 2024 

Mr. MCCORMICK (for himself, Mr. ALFORD, Mr. ALLEN, Mr. ARRINGTON, Mr. 

BIGGS, Ms. BOEBERT, Mr. BURLISON, Mr. CLINE, Mr. CLYDE, Mr. COLLINS, Mr. DUNCAN, Mr. SCOTT FRANKLIN of Florida, Mr. MIKE GARCIA

of California, Mr. TONY GONZALES of Texas, Mr. GOODEN of Texas, Mr. 

GROTHMAN, Mr. HARRIS, Mrs. HARSHBARGER, Mr. JACKSON of Texas, 

Mr. KELLY of Mississippi, Mr. LAMBORN, Mrs. LUNA, Mrs. MILLER of 

Illinois, Mrs. MILLER of West Virginia, Mr. MOONEY, Mr. MOORE of Alabama, Mr. MURPHY, Mr. NEHLS, Mr. NORMAN, Mr. OGLES, Mr. POSEY, 

Mr. ROUZER, Mr. AUSTIN SCOTT of Georgia, Mr. STEUBE, Ms. TENNEY, 

Mr. TIFFANY, Mr. TIMMONS, Mr. VAN DREW, Ms. VAN DUYNE, Mr. 

WEBER of Texas, Mr. BABIN, Mrs. LESKO, Mr. WILLIAMS of Texas, Mr. 

LOUDERMILK, and Mr. WESTERMAN) introduced the following bill; which 

was referred to the Committee on Energy and Commerce 

A BILL 

To prohibit Federal funds from being used to provide certain 

gender transition procedures to minors. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 


ssavage on LAPJG3WLY3PROD with BILLS
2 

•HR 7183 IH

1 SECTION 1. SHORT TITLE. 

2 This Act may be cited as the ‘‘Protecting Resources 

3 Of Taxpayers to Eliminate Childhood Transgender Sur4 geries Act of 2024’’ or the ‘‘PROTECTS Act of 2024’’. 

5 SEC. 2. PROHIBITING FEDERAL FUNDS FROM BEING USED 

6 TO PROVIDE CERTAIN GENDER TRANSITION 

7 PROCEDURES TO MINORS. 

8 (a) IN GENERAL.—Notwithstanding any other provi9 sion of law, no Federal funds may be used or otherwise 

10 made available to provide or refer for a specified gender 

11 transition procedure to an individual under the age of 18 

12 or to reimburse any entity for providing such a procedure 

13 to such an individual. 

14 (b) SPECIFIED GENDER TRANSITION PROCEDURE

15 DEFINED.— 

16 (1) IN GENERAL.—For purposes of this para17 graph, except as provided in paragraph (2), the term 

18 ‘‘specified gender transition procedure’’ means, with 

19 respect to an individual, any of the following when 

20 performed for the purpose of intentionally changing 

21 the body of such individual to no longer correspond 

22 to their sex: 

23 (A) Performing any surgery, including— 

24 (i) castration; 

25 (ii) orchiectomy; 

26 (iii) scrotoplasty; 


ssavage on LAPJG3WLY3PROD with BILLS
3 

•HR 7183 IH

1 (iv) vasectomy; 

2 (v) hysterectomy; 

3 (vi) oophorectomy; 

4 (vii) ovariectomy; 

5 (viii) metoidioplasty; 

6 (ix) penectomy; 

7 (x) phalloplasty; 

8 (xi) vaginoplasty; 

9 (xii) vaginectomy; 

10 (xiii) vulvoplasty; 

11 (xiv) reduction thyrochondroplasty; 

12 (xv) chondrolaryngoplasty; 

13 (xvi) mastectomy; and 

14 (xvii) any plastic, cosmetic, or aes15 thetic surgery that feminizes or 

16 masculinizes the facial or other body fea17 tures of an individual. 

18 (B) Any placement of chest implants to 

19 create feminine breasts. 

20 (C) Any placement of fat or artificial im21 plants in the gluteal region. 

22 (D) Administering, supplying, prescribing, 

23 dispensing, distributing, or otherwise conveying 

24 to an individual medications, including— 


ssavage on LAPJG3WLY3PROD with BILLS
4 

•HR 7183 IH

1 (i) gonadotropin-releasing hormone 

2 (GnRH) analogues or other puberty-block3 ing drugs to stop or delay normal puberty; 

4 and 

5 (ii) testosterone, estrogen, or other 

6 androgens to an individual at doses that 

7 are supraphysiologic than would normally 

8 be produced endogenously in a healthy in9 dividual of the same age and sex. 

10 (2) EXCEPTION.—Paragraph (1) shall not 

11 apply to the following when furnished to an indi12 vidual by a health care provider with the consent of 

13 such individual’s parent or legal guardian: 

14 (A) Puberty suppression or blocking pre15 scription drugs for the purpose of normalizing 

16 puberty for an individual experiencing pre17 cocious puberty. 

18 (B) Appropriate and medically necessary 

19 procedures or treatments to correct for— 

20 (i) a medically verifiable genetic dis21 order of sex development, including— 

22 (I) 46,XX chromosomes with 

23 virilization; 

24 (II) 46,XY chromosomes with 

25 undervirilization; and 


ssavage on LAPJG3WLY3PROD with BILLS
5 

•HR 7183 IH

1 (III) both ovarian and testicular 

2 tissue; 

3 (ii) sex chromosome structure, sex 

4 steroid hormone production, or sex hor5 mone action, if determined to be abnormal 

6 by a physician through genetic or bio7 chemical testing; or 

8 (iii) infection, disease, injury, or dis9 order caused or exacerbated by a previous 

10 procedure described in paragraph (1), or a 

11 physical disorder, physical injury, or phys12 ical illness that would, as certified by a 

13 physician, place the individual in imminent 

14 danger of death or impairment of a major 

15 bodily function unless the procedure is per16 formed, not including procedures per17 formed for the alleviation of mental dis18 tress. 

19 (3) SEX.—For purposes of paragraph (1), the 

20 term ‘‘sex’’ means the indication of male or female 

21 sex by reproductive potential or capacity, sex chro22 mosomes, naturally occurring sex hormones, gonads, 

23 or internal or external genitalia present at birth. 

Æ 


ssavage on LAPJG3WLY3PROD with BILLS